Trials / Completed
CompletedNCT02515747
Prospective Russian Evaluation of Lp(a) Role in cardiovascUlar DiseasE
Role of Lipoprotein(a) Concentration and Apolipoprotein(a) Phenotype in Prediction of Coronary Events in General Population
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,400 (actual)
- Sponsor
- Russian Cardiology Research and Production Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to explore the role of lipoprotein(a) and apolipoprotein(a) phenotype in fatal and non-fatal cardiovascular disease (CVD) events risk in coronary disease patients divided on the basis of management strategy - medical, endovascular or open cardiac surgery.
Detailed description
Between January 1993 and September 2006, we enrolled 1400 consecutive patients from the Atherosclerosis Department with known Lp(a) levels and coronary heart disease (CHD) verified by angiography. In accordance with clinical condition and angiography data were assigned them into three parallel treatment arms and followed up to 15 years. This study was conducted according to the principles of the Declaration of Helsinki and the Institutional Ethics Committee.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | percutaneous coronary intervention | elective percutaneous coronary balloon angioplasty and/or stenting |
| PROCEDURE | coronary artery bypass grafting | elective surgical myocardial revascularisation |
Timeline
- Start date
- 1993-01-01
- Primary completion
- 2006-09-01
- Completion
- 2014-01-01
- First posted
- 2015-08-05
- Last updated
- 2015-08-05
Source: ClinicalTrials.gov record NCT02515747. Inclusion in this directory is not an endorsement.